share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Feb 29 21:07

Gainers

  • Enveric Biosciences (NASDAQ:ENVB) stock rose 162.3% to $2.18 during Thursday's pre-market session. The company's market cap stands at $5.9 million.
  • Societal CDMO (NASDAQ:SCTL) shares moved upwards by 134.78% to $1.08. The company's market cap stands at $113.1 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 45.11% to $7.43. The company's market cap stands at $36.4 million.
  • OneMedNet (NASDAQ:ONMD) stock moved upwards by 28.97% to $0.89. The market value of their outstanding shares is at $28.7 million.
  • Establishment Labs Hldgs (NASDAQ:ESTA) stock increased by 21.91% to $46.89. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out yesterday.
  • Avidity Biosciences (NASDAQ:RNA) shares moved upwards by 20.64% to $18.41. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • Ironwood Pharmaceuticals (NASDAQ:IRWD) shares decreased by 27.7% to $10.94 during Thursday's pre-market session. The company's market cap stands at $1.7 billion.
  • Milestone Pharmaceuticals (NASDAQ:MIST) stock fell 20.19% to $1.7. The market value of their outstanding shares is at $56.9 million.
  • Butterfly Network (NYSE:BFLY) stock fell 14.19% to $1.27. The company's market cap stands at $263.0 million. The company's, Q4 earnings came out yesterday.
  • Schrodinger (NASDAQ:SDGR) stock fell 13.3% to $27.2. The market value of their outstanding shares is at $1.9 billion. The company's, Q4 earnings came out yesterday.
  • ClearPoint Neuro (NASDAQ:CLPT) shares declined by 13.22% to $6.7. The company's market cap stands at $164.9 million.
  • Ampio Pharmaceuticals (AMEX:AMPE) stock fell 13.05% to $2.0. The market value of their outstanding shares is at $2.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment